Showing results (2961-2970 of 5,227) with videos related to

Sort By:
Pageof 523
Antiviral Research|January 1, 1992
Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replicationJ C Lin, J Reefschläger, G Herrmann, et al.
Antiviral Research|December 13, 2003
Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfateHåvard Jenssen, Jeanette Hammer Andersen, Lars Uhlin-Hansen, et al.
Antiviral Research|December 13, 2003
In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combinationS Briolant, D Garin, N Scaramozzino, et al.
Antiviral Research|December 13, 2003
Genotypic resistance profile in treatment-experienced HIV-infected individuals after abacavir and efavirenz salvage regimenAlejandro Vallejo, Mercedes Olivera, Amalia Rubio, et al.
Antiviral Research|June 1, 1992
The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitroJ Balzarini, J Neyts, D Schols, et al.
Antiviral Research|June 18, 2019
Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systemsYasunori Nio, Machiko Sasai, Yuichi Akahori, et al.
Antiviral Research|July 7, 2019
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1Joseph J Eron, Chloe Orkin, Douglas Cunningham, et al.
Antiviral Research|October 9, 2019
Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infectionDmitry Shcheblyakov, Ilias Esmagambetov, Pavel Simakin, et al.
Antiviral Research|July 10, 2019
Altered monocyte response to the dengue virus in those with varying severity of past dengue infectionAchala Kamaladasa, Laksiri Gomes, Ayesha Wijesinghe, et al.
Antiviral Research|July 10, 2019
Non-invasive biomarkers for chronic hepatitis B virus infection managementCaroline Charre, Massimo Levrero, Fabien Zoulim, et al.
Pageof 523